ALA
LLY icon

Atlas Legacy Advisors’s Eli Lilly LLY Stock Holding History

Atlas Legacy Advisors’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.05M Sell
1,145
-401
-26% -$407K 0.19% 81
2025
Q4 		$1.65M Buy
1,546
+79
+5% +$75.5K 0.29% 64
2025
Q3 		$1.12M Buy
1,467
+713
+95% +$531K 0.22% 73
2025
Q2 		$588K Sell
754
-17
-2% -$13.2K 0.13% 106
2025
Q1 		$637K Buy
771
+7
+0.9% +$5.83K 0.16% 88
2024
Q4 		$590K Buy
+764
New +$633K 0.14% 91

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Atlas Legacy Advisors's LLY Position: Q1 2026 in Review

Atlas Legacy Advisors reduced its Eli Lilly (LLY) stake by 26% in Q1 2026, selling an estimated $407K and leaving 1,145 shares worth $1.05M. The position accounts for 0.19% of the portfolio, ranked #81.

Atlas Legacy Advisors first reported a position in LLY in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.65M in Q4 2025. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Atlas Legacy Advisors held 1,145 shares of Eli Lilly worth $1.05M as of Q1 2026.
  • Atlas Legacy Advisors sold 401 Eli Lilly shares in Q1 2026, an estimated $407K.
  • Eli Lilly made up 0.19% of Atlas Legacy Advisors's portfolio in Q1 2026, its #81 holding.
  • Atlas Legacy Advisors first reported a position in Eli Lilly in Q4 2024 and has held it in 6 quarters since.
  • Atlas Legacy Advisors's Eli Lilly position peaked at $1.65M in Q4 2025.
  • 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Atlas Legacy Advisors's 13F filing for Q1 2026, filed 11 May 2026.